Centurion Patentors as of February 25, 2025

Oghenekome Oteri

Systems Engineering at Apple.

Patent №:  12238763 – MsgA PUSCH validation.

A UE determines an initial UL/DL slot configuration, receives a cell-specific UL/DL slot from a base station, generates a MsgA PUSCH occasion (PO), and validates whether the MsgA PO is in a permissible transmission slot.

Patent №:  12238716 – Techniques for PDSCH/PUSCH processing for multi-TRP. The UE determines an initial UL/DL slot configuration, receives a cell-specific UL/DL slot configuration from a base station, generates a MsgA PUSCH occasion (PO), and performs a validation test to ensure it is in a permissible transmission slot.

Patent №:  12238551 – Network operations to reduce PDCCH monitoring. Techniques for multi-TRP PDSCH and PUSCH processing involve determining HARQ-ACK timing for a UE in single-DCI operation by calculating the minimum processing time using symbols from one or both PDSCHs.

Patent №:  12238027 – Timing-related considerations for network-controlled repeaters. A repeater receives side control information from a network, determines time-domain resources for applying a beam to transmission (Tx) and/or reception (Rx) spatial filters, and applies the beam accordingly for UL reception or DL forwarding between a UE and the network.

Patent №:  12237885 – Multiple input multiple output (MIMO) setup in millimeter wave (MMW) WLAN systems. An AP/PCP selects, pairs, or groups users based on analog transmission measurements like SNR or SINR. Stations report the best and worst beam pairs for Tx and Rx virtual antennas, which the AP/PCP uses to optimize grouping and communication efficiency.

Peter Forsell

Dr. Peter Forsell is a Swedish inventor, surgeon, and medical device entrepreneur. He is the CEO and Founder of Implantica AG, known for RefluxStop™, a breakthrough acid reflux treatment approved in 2018.

A specialist in surgery with a medical degree from Karolinska Institute, he has also studied law, tax, and finance. Previously, he was Executive Chairman of Obtech Medical AG, which developed the gastric band and captured 28% of the non-US obesity surgery market before being sold to Johnson & Johnson.

Patent №: 12233374 – Implantable fluid movement device. An apparatus for moving fluid to or from a body cavity includes a fluid movement device, an energy source, and at least one connecting tube. Designed for implantation, the device moves fluid between a treatment and delivery area. A flexible patch with a net structure promotes fibrotic tissue growth for secure integration.

Patent №: 12232954 – Artificial valve. A method for implanting an artificial valve in a blood vessel involves positioning a valve with a casing and a closing mechanism. The closing mechanism includes a movable part that transitions between open, closed, and intermediate positions to regulate blood flow.

Patent №:  12232953 – Artificial valve. An auxiliary artificial valve for implantation in a blood vessel includes a casing with at least one hinge and two movable parts. These parts transition between open and closed positions and are movably attached to the casing via the hinge for controlled blood flow regulation.

Gregory J Bakos

Patent Manager at Johnson & Johnson.

Mechanical engineer and registered patent agent with a broad background in medical devices. Creative thinker stimulated by challenging problems.

Patent №:  12232728 – Method of surgical stapling with end effector component having a curved tip.

A surgical stapling method uses an instrument with a body, shaft, and end effector with jaws. A placement tip extends from one jaw. The method includes positioning the end effector, opening the jaws, placing tissue between them, clamping the tissue, and advancing a firing beam to staple and cut.